Innovative Gene-Editing 'Molecular Scissors' Offer New Hope for Chronic Hepatitis B Treatment
Advances in gene-editing technology using TALENs show promise in targeting and eliminating the stubborn cccDNA of hepatitis B, offering hope for more effective treatments and potential cures for millions affected worldwide.
Recent advancements in gene-editing technology have introduced a promising approach to combating chronic hepatitis B (HBV), a persistent viral infection that affects millions worldwide, especially in regions like South Africa. Researchers led by Dr. Tiffany Smith of the Antiviral Gene Therapy Research Unit have developed a novel method utilizing TALENs (transcription activator-like effector nucleases) to precisely target and disable the virus's genetic material.
Unlike other gene-editing tools such as CRISPR, TALENs do not rely on guide RNAs, making them effective even in complex DNA structures. The team's breakthrough centers on targeting covalently closed circular DNA (cccDNA), the 'mini chromosome' that HBV uses to hide within liver cells and sustain infection. Current treatments can suppress virus activity but cannot eradicate cccDNA, leading to potential relapse after therapy cessation.
Preclinical studies have shown significant results: in cultured human liver cells, the treatment reduced hepatitis B markers by 80%, and in infected mice, a single dose caused a 99% reduction in circulating viral DNA. Importantly, the therapy was well tolerated, with only mild, temporary inflammation observed.
This innovation could pave the way for more effective, possibly curative, treatments for HBV. The team is combining TALENs with mRNA delivery via lipid nanoparticles, a platform previously successful in vaccine development, to enhance precision and safety. While further research is needed to confirm these findings in humans, this development marks a significant step toward a functional cure for hepatitis B.
Hepatitis B remains a major health concern, especially in resource-limited settings where lifelong antiviral therapy is burdensome. The potential to directly eliminate the virus's genetic blueprint offers hope for a future where hepatitis B can be effectively controlled or eradicated.
Source: https://medicalxpress.com/news/2025-08-generation-molecular-scissors-chronic-hepatitis.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Innovative Brain Organoid Platform Aims to Elucidate Repeated Low-Level Blast Injuries in Military Brain Trauma Research
A pioneering brain organoid platform developed by Johns Hopkins researchers aims to unlock the mysteries of repeated low-level blast injuries in military personnel, advancing TBI research and prevention strategies.
Breakthrough AI-Powered Imaging Enhances Visualization of Retinal Cells
Duke University researchers have developed an AI-driven retinal imaging system that provides faster, more detailed visualization of retinal cells, enhancing early diagnosis of neurological and eye diseases.
Innovative Perovskite Camera Enables Inside-Body Imaging for Medical Diagnostics
A breakthrough in medical imaging technology using perovskite crystals offers high-resolution, cost-effective inside-body scans—potentially revolutionizing nuclear medicine diagnostics.
Exploring the Dual Impact of AI Scribes in Healthcare
An editorial in JMIR Medical Informatics explores the promising benefits and significant challenges of integrating AI scribes into healthcare, highlighting the need for careful, evidence-based implementation to ensure patient safety and clinician well-being.